Orchard’s Gene Therapy Under Fast-Track Review At EMA

 
• By Maureen Kenny

A handful of new products are under review at the European Medicines Agency. Orchard Therapeutics' gene therapy application will be fast-tracked; Roche's filing for its new flu treatment will not.

Microscope
Some new products are under the microscope at the EMA • Source: Shutterstock

More from Product Reviews

More from Pink Sheet